2017
DOI: 10.1016/j.ultrasmedbio.2017.07.010
|View full text |Cite
|
Sign up to set email alerts
|

Role of Contrast-Enhanced Ultrasound in the Pre-operative Diagnosis of Cervical Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
82
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 50 publications
(91 citation statements)
references
References 33 publications
6
82
3
Order By: Relevance
“…Their results showed that heterogeneous enhancement, perfusion defects, microcalcification, and centripetal/hybrid enhancement were specific criteria for malignant lymph nodes in a univariate analysis. Furthermore, Hong et al [ 51 ] reported a similar conclusion.…”
Section: Ceus Detection Of Extrathyroid Extension or Neck Lymph Node mentioning
confidence: 56%
“…Their results showed that heterogeneous enhancement, perfusion defects, microcalcification, and centripetal/hybrid enhancement were specific criteria for malignant lymph nodes in a univariate analysis. Furthermore, Hong et al [ 51 ] reported a similar conclusion.…”
Section: Ceus Detection Of Extrathyroid Extension or Neck Lymph Node mentioning
confidence: 56%
“…With the development of ultrasound imaging and ultrasound elastography, its application in the diagnosis of lymph node metastasis is becoming more and more common. Contrast-enhanced ultrasound and elastography have been reported in the literature for preoperative diagnosis of PTC cervical lymph node metastasis[18-20]. However, regardless of contrast-enhanced ultrasound or elastography, the accuracy of individual diagnosis is unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Ethical approval was obtained from the Ethical Committees of Chinese PLA General Hospital. Inclusion criteria were: (1) patients received total or subtotal thyroidectomy for PTC, and at least one subsequent neck dissection; (2) patients who had contraindications for surgery or refused surgery, or refused to undergo further surgical resection and absent radioiodine uptake at post-therapeutic 131I whole-body scan; (3) patients with at least one metastatic lymph node (which were ready for treatment) confirmed by US-guided biopsy, or confirmed by US and CEUS (Figures 1 and 2) [26]; (4) no evidence of distant metastases. The flowchart of patient selection process was shown in Figure 3.…”
Section: Study Populationmentioning
confidence: 99%